Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India

AIDS

Volumn 22, Issue SUPPL. 5, 2008, Pages

  Mahanta, Jagadish ^a,f   Medhi, Gajendra Kumar ^a   Paranjape, Ramesh S ^b   Roy, Nandan ^c   Kohli, Anjalee ^c   Brogen Akoijam, S ^d   Dzuvichu, Bernice ^e   Das, Hiranya Kumar ^a   Goswami, Prabuddhagopal ^c   Thongamba, Gay ^c  

^a REGIONAL MEDICAL RESEARCH CENTRE   (India)

^b NATIONAL AIDS RESEARCH INSTITUTE   (India)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d REGIONAL INSTITUTE OF MEDICAL SCIENCES   (India)

^e Kripa Foundation   (India)

^f INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

HIV; India; Injecting drug user; Maharashtra; Manipur; Nagaland; Respondent driven sample

Indexed keywords

CHLORPHENIRAMINE; DEXTROPROPOXYPHENE; DIAMORPHINE;

ADULT; ARTICLE; CONTROLLED STUDY; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INDIA; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; UNSAFE SEX;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; BLOOD-BORNE PATHOGENS; CONDOMS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INDIA; MALE; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 58849098703     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000343764.62455.9e     Document Type: Article

References (43)

1. Charles M, Bewley-Taylor D, Neidpath A. Drug policy in India: compounding Harm? Briefing paper 10 - The Beckley Foundation Drug Policy Program. 2005; 1-6.
2. UNODC. World Drug Report 2004. Available at: www.unodc.org/ pdfAVDR-2004/volume-2.pdf. Accessed 10 October 2008.
3. Crofts N, Reid C, Deany P. Injecting drug use and HIV infection in Asia. AIDS 1998; 12 (Suppl. B):S69-S78.
4. Sarkar S, Das N, Panda S, Naik TN, Sarkar K, Singh BC, et al. Rapid spread of HIV among injecting drug users in northeastern states of India. Bull Narc 1993; 45:91-105.
5. National AIDS Control Organization. HIV sentinel surveillance and HIV estimation 2006. Available at: www.nacoonline.org. Accessed 10 February 2008.
6. Aceijas C, Stimson C, Hickman M, Rhodes T, and UN Reference Croup on HIV/AIDS. Prevention and care among IDU in developing and transitional countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18:2295-2303.
7. Rothwell M, Latkin C. HIV-related communication and perceived norms: an analysis of the connection among injection drug users. AIDS Educ Prevent 2007; 19:298-310.
8. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of international evidence. Subst Use Misuse 2006; 41:777-813.
9. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001; 15:1329-1341.
10. UNODC. Drug use in northeastern states of India 2006. Available at: http://www.unodc.org/india/drug-use-in-ne.html. Accessed: 17 June 2008.
11. The World Bank. Preventing HIV/AIDS in India 2005. Available at: www.worldbank.org. Accessed: 20 March 2008.
12. Eicher AD. Injecting drug use and HIV risks in Churachandpur town, Manipur state, north-east India. Int Conf AIDS 1996; 11:46 [Abstract no. C1175].
13. Pisani E, Dadun, Sucahya PK, Kamil O, Jazan S. Sexual behavior among injecting drug users in 3 Indonesian cities carries a high potential for HIV spread to noninjectors. J Acquir Immune Defic Syndr 2003; 34:403-406.
14. Panda S, Kumar MS, Lokabiraman S, Jayashree K, Satagopan MC, Solomon S, et al. Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic Syndr 2005; 39:9-15.
15. National AIDS Control Organization. Manipur: HIV surveillance fact sheets 2003 -2006. Available at: www.nacoonline.org. Accessed: 20 March 2008.
16. National AIDS Control Organization. Nagaland HIV surveillance fact ssheets 2003-2006. Available at: www.nacoonli-ne.org. Accessed: 20 March 2008.
17. Singh TN, Kananbala S, Thongam W, Devi KS, Singh NB. Increasing trend of HIV seropositivity among commercial sex-workers attending the Voluntary and Confidential Counseling and Testing Centre in Manipur, India. Int J STD and AIDS 2005; 16:166-169.
18. Chandrasekaran P, Dallabetta G, Loo V, Mills S, Saidel T, Adhikary R, et al. Evaluation design for measuring the impact of the first phase of a large scale HIV prevention effort in India: Avahan, the India AIDS Initiative. AIDS 2008; 22 (Suppl. 5):S1-S15.
19. Heckathorn DD. Respondent driven sampling: a new approach to the study of hidden populations. Social Problems 1997; 44:74-199.
20. Heckathorn DD. Respondent driven sampling II: deriving valid population estimates from chain referral samples of hidden populations. Social Problems 2002; 49:11-34.
21. Salganik M, Heckathorn DD. Sampling and estimation in hidden populations using respondent driven sampling. Soc Meth-odol 2004; 34:193-239.
22. MAP Report 2005. Drug injection and HIV/AIDS in Asia. Available at: www.mapnetwork.org. Accessed: 23 June 2008.
23. Wood E, Li K, Miller CL, Hogg RS, Montaner JSG, Schechter MT, et al. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users. Int J Epidemiol 2005; 34:152-158.
24. Fennema JS, Van Ameijden EJ, Van Den Hoek A, Coutinho RA. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 1997; 92:1457-1465.
25. Carneiro M, Fuller C, Doherty MC, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug Alcohol Depend 1999; 54:83-86.
26. Marrero RCA, Robles RR, Colon HM, Freeman DH, Matos TD, Reyes JC. HIV risk behaviors and HIV seropositivity among young injection drug users. PR Health Sci J 1993; 12:7-12.
27. Buxton MB, Vlahov D, Strathdee SA, Des Jarlais DC, Morse EV, Ouellet L, et al. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alc Depend 2004; 75:1 77-183.
28. Fuller CM, Vlahov D, Latkin CA, Ompad DC, Celentano DD, Strathdee SA. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young a dull injection drug users. J Acquir Immune Defic Syndr 2003; 32:86-93.
29. Kermode M, Longleng V, Singh BC, Hocking J, Langkham B, Crofts N. My first time: initiation into injecting drug use in Manipur and Nagaland, north-east India. Harm Reduction J 2007; 4:1-11.
30. Hangzo C, Chatterjee A, Sarkar S, Zomi G, Deb BC, Abdul-Quader AS. Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India. Addiction 1997; 92:813-820.
31. Eicher AD, Crofts N, Benjamin S, Deutschmann P, Rodger AJ. A certain fate: spread of HIV among young injecting drug users in Manipur, northeast India. AIDS Care 2000; 12:497-504.
32. Cohen J. HIV/AIDS in India: the needle and the damage done. Science 2004; 304:509-512.
33. Rhodes T, Simic M. Transition and HIV Risk environment. BMJ 2005; 331:220-223.
34. Cornell TA, Kuyper LM, Shoveller J, Hogg RS, Li K, Spittal PM, et al. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place 2006; 12:78-85.
35. Costenbader EC, Astone NM, Latkin CA. The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction 2006; 101:1003-1013.
36. Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Commun Psychol 1994; 22:415-430.
37. Koester S, Booth R, Wiebel W. The risk of HIV transmission from sharing water, drug mixing containers and cotton filters among intravenous drug users. Available at: http://www.drugtext.org/index.html. Accessed: 17 June 2008.
38. Becker M, Reza-Paul S, Ramesh BM, Washington R, Moses S, Blanchard J. Association between medical injections and HIV infection in a community based study in India. AIDS 2005; 19:1334-1336.
39. Agarwal AK, Singh NY, Devi LB, Shyamkanhai KH, Bhattacharya SK, Singh YM. Clinical features of HIV progression as observed longitudinally in a cohort of injecting drug users in Manipur. Indian J Med Res 1998; 108:11-22.
40. Koester S, Glanz J, Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav 2005; 9:27-39.
41. Saha MK, Chakrabarti S, Panda S, Naik TN, Manna B, Chatterjee A, et al. Prevalence of HCV and HBV infection among HIV seropositive intravenous drug users and their noninjec-ting wives in Manipur, India. Indian J Med Res 2000; 111:37-39.
42. Rhodes T, Sarang A, Bobrik A, Bobkov E, Piatt L. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Int J Drug Policy 2004; 15: 1-16.
43. Chakrabarti S, Panda S, Chatterjee A, Sarkar S, Manna B, Singh B, et al. HIV-1 subtypes in injecting drug users and their non-injecting wives in Manipur. Indian J Med Res 2000; 111:89-94.